AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Saes Getters

Earnings Release May 12, 2022

4297_rns_2022-05-12_6828d54d-8034-426b-a743-00e1644a332f.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

PRESS RELEASE Milan, May 12, 2022

STRONG ORGANIC GROWTH IN CONSOLIDATED REVENUES AND IN ALL OPERATING INDICATORS COMPARED TO BOTH 1Q 2021 AND 4Q 2021

  • Consolidated net revenues equal to €59.2 million, up by 44.1% compared to €41 million in 1Q 2021 still penalized by the pandemic
  • Consolidated net revenues up by 11.5% compared to €53.1 million in 4Q 2021
  • Consolidated gross profit equal to €26 million, compared to €15.9 million in 1Q 2021 (€23.3 million in 4Q 2021)
  • Gross margin up from 38.8% to 44% in 1Q 2022 (43.9% in 4Q 2021)
  • Consolidated operating income equal to €10.3 million, compared to €2.2 million in 1Q 2021 (€5.6 million in 4Q 2021)
  • Consolidated EBITDA equal to €13.7 million (23.1%), compared to €5 million in 1Q 2021 (12.2%) and €10.4 million (19.6%) in 4Q 2021
  • Consolidated net income equal to €1.9 million, heavily penalized by the negative performance of securities portfolio (-€5.5 million) due to the Ukraine-Russia crisis
  • Consolidated net financial position positive and equal to €71 million as at March 31, 2022
  • Due diligence for the acquisition of 100% of SAES RIAL Vacuum S.r.l. completed

The Board of Directors of SAES Getters S.p.A., gathered today in Milan, approved the consolidated results of the first quarter of 2022 (January 1 - March 31).

"We are extremely satisfied with the results of SAES in the first quarter of 2022. All sectors recorded a strong growth, also thanks to the excellent trend of the euro-dollar exchange rate - Eng. Massimo della Porta, President of SAES Getters S.p.A. said - We expect the current situation of the Group to continue in the coming months, also thanks to the minimal operating impact of the difficult international geopolitical situation on SAES".

In the first quarter of 2022 the SAES® Group achieved consolidated net revenues equal to €59.2 million, compared to €41 million in the corresponding quarter of 2021. Excluding the exchange rate effect, positive and equal to +6.7% and the effect of the change in the scope of consolidation due to the acquisition of Strumenti Scientifici Cinel S.r.l. in July 2021 (+3.8%), the organic growth was equal to +33.7%. However, the comparison is not significant due to the still penalizing effect of the pandemic in the first months of 2021, mainly in the medical Nitinol business, penalized by the postponement of elective therapies.

All the Divisions recorded an organic growth, in particular the Medical Nitinol Division (+42.3%, equal to €7.6 million), favored by the post-Covid recovery and the related restocking actions. Also the High Vacuum Division recorded a strong organic growth (+63.7%, equal to €2 million), thanks to higher sales of vacuum pumps in all segments (particle accelerators, research institutes and industry), to which were added the revenues for the supply of vacuum systems to the RFX Consortium of Padua, active in experimental nuclear

SAES Group – Press Release
fusion. Finally, please note the strong increase in the Packaging Division (+114.1%, equal to €1.9 million),
that consolidated the signs of growth already observed at the end of 2021, due both to the expansion of the
customer portfolio and to the higher penetration of SAES products that represent an alternative to the use
of some plastic raw materials for which there is currently a market shortage.
Thousands of euro (except %)
Total Organic Exchange rate Perimeter
Business 1Q 2022 1Q 2021 difference change effect variation (%)
(%) (%) (%)
4.6% 0.3% 4.3% 0.0%
Getters & Dispensers 11,738 11,217
Sintered Materials 2,560 1,900 34.7% 25.4% 9.3% 0.0%
SMA Materials 3,441 2,846 20.9% 17.9% 3.0% 0.0%
SAES Industrial 17,739 15,963 11.1% 6.5% 4.6% 0.0%
High Vacuum Solutions 6,887 3,182 116.4% 63.7% 4.0% 48.7%
SAES High Vacuum 6,887 3,182 116.4% 63.7% 4.0% 48.7%
Medical Nitinol 27,469 17,985 52.7% 42.3% 10.4% 0.0%
SAES Medical Nitinol 27,469 17,985 52.7% 42.3% 10.4% 0.0%
Chemicals 3,423 2,209 55.0% 55.0% 0.0% 0.0%
SAES Chemicals 3,423 2,209 55.0% 55.0% 0.0% 0.0%
Packaging Solutions
SAES Packaging
3,638
3,638
1,699
1,699
114.1%
114.1%
114.1%
114.1%
0.0%
0.0%
0.0%
0.0%

Also in this case, the increase was concentrated in the Medical Nitinol Division (+12.4%, equal to €3 million, attributable both to the continuous growth of the final market and to the need to recover surgeries deferred during the Covid period as well as to the consequent restocking actions), in the Packaging Division (+90.6%, or €1.7 million, thanks to the consolidation of the success of the barrier technology offered by SAES in the market) and in the Industrial Division (+10.3%, or €1.6 million; a growth mainly concentrated in the SMA Materials business and distributed in all reference markets, namely luxury, automotive, consumer electronics and medical drug dispensing).

Finally, please note the organic breakeven of the High Vacuum Division and the organic decrease of the Chemicals Division attributable to the physiological slowdown that occurs every year in the first quarter compared to the fourth quarter of the previous year (-21.8%, equal to €1 million).

Total Organic Exchange rate
Business 1Q 2022 4Q 2021 difference change effect
(%) (%) (%)
Getters & Dispensers 11,738 11,124 5.5% 4.3% 1.2%
Sintered Materials 2,560 2,323 10.2% 8.1% 2.1%
SMA Materials 3,441 2,447 40.6% 39.6% 1.0%
SAES Industrial 17,739 15,894 11.6% 10.3% 1.3%
High Vacuum Solutions 6,887 6,901 -0.2% -0.9% 0.7%
SAES High Vacuum 6,887 6,901 -0.2% -0.9% 0.7%
Medical Nitinol 27,469 23,978 14.6% 12.4% 2.2%
SAES Medical Nitinol 27,469 23,978 14.6% 12.4% 2.2%
Chemicals 3,423 4,376 -21.8% -21.8% 0.0%
SAES Chemicals 3,423 4,376 -21.8% -21.8% 0.0%
Packaging Solutions 3,638 1,909 90.6% 90.6% 0.0%
SAES Packaging 3,638 1,909 90.6% 90.6% 0.0%
Total Net Sales 59,156 53,058 11.5% 10.0% 1.5%

Thousands of euro (except %)

Including also the share of the revenues of the joint ventures1 , total revenues of the Group were equal to €60.3 million, compared to €43.6 million in the first quarter of 2021. The increase, equal to 38.2%, was exclusively due to the increase in consolidated net revenues (+44.1%), while the revenues of the joint venture Actuator Solutions GmbH were down (in the automotive sector sales were penalized by uncertainties on the supply chain and by the shortage of semiconductors; in the engineering and development sector there were lower sales of devices for Covid-19 rapid diagnostic tests), as well as those of the joint venture SAES RIAL Vacuum S.r.l. (sales were down following the conclusion of a particle accelerator project from which the company had benefited in the previous year). 1Q 2022 1Q 2021 Difference Consolidated sales 59,156 41,038 18,118 Total revenues of the Group 60,316 43,644 16,672

Thousands of euro
50% sales of the joint venture Actuator Solutions GmbH 734 2,163 (1,429)
49% sales of the joint venture SAES RIAL Vacuum S.r.l. 497 626 (129)
46.84% sales of the joint venture Flexterra 0
0
0
Intercompany eliminations (56) (267) 211
Other adjustments (15) 84 (99)

Consolidated gross profit2 was equal to €26 million in the first quarter of 2022, strongly increased (+63.6%) compared to €15.9 million in the corresponding period of 2021, despite the penalizing effect of the energy expenses in the Italian manufacturing plants. All the Divisions recorded a growth, with the increase being mainly driven by higher revenues and their subsequent economies of scale, particularly in the Medical Nitinol Division and in the High Vacuum Division. Please note that the acquisition of Strumenti Scientifici Cinel S.r.l. contributed to the increase of gross profit for €0.5 million, while the exchange rate effect was positive and equal to €1.3 million.

Compared to fourth quarter of 2021, gross profit increased by +11.8% (from €23.3 million to €26 million), favored by the Industrial Division (mainly the SMA Materials business), as well as by the Medical Nitinol one.

Gross margin3 increased from 38.8% to 44%, in line with that of the last quarter of 2021 (43.9%). In the comparison between the first two quarters, also the gross margin, as well as the gross profit, increased in all the Divisions, particularly in the Medical Nitinol one, that has been progressively improving the production yield of the new tube department.

Consolidated operating income amounted to €10.3 million (17.3% of revenues) in the first quarter of 2022, showing an extraordinary growth compared to an operating income of €2.2 million (5.5% of revenues) in the first quarter of the previous year: the growth was the consequence of the better industrial performance of all the Divisions, despite the increase in operating expenses (especially personnel costs, related to the increase in the Group's workforce). Please note that the acquisition of Strumenti Scientifici Cinel S.r.l. contributed to the increase in the operating income for €0.3 million, while the exchange rate effect was positive and equal to €1 million.

Also compared to the fourth quarter of 20214 , both the operating income and the operating margin recorded a significant growth (+82.1% the increase in absolute terms, while the operating margin increased from 10.6% to 17.3%).

1 Actuator Solutions (50%), SAES RIAL Vacuum S.r.l. (49%) and Flexterra (46.84%).

2 Calculated as the difference between net sales and industrial costs directly and indirectly attributable to the products sold.

3 Calculated as the ratio between gross profit and consolidated revenues.

4 Please note that the operating income in the fourth quarter of 2021 was penalized by the write-down for impairment test in the packaging business (€1.5 million) and by the cancellation of an advance for a potential equity investment, which was then suspended, again in the packaging business (€1.1 million).

SAES Group – Press Release
Thousands of euro
SAES Industrial SAES High Vacuum SAES Medical Nitinol SAES Chemicals SAES Packaging Not Allocated TOTAL
1Q 2022 1Q 2021 1Q 2022 1Q 2021 1Q 2022 1Q 2021 1Q 2022 1Q 2021 1Q 2022 1Q 2021 1Q 2022 1Q 2021 1Q 2022 1Q 2021
Total net sales
Cost of sales
17,739
(8,487)
15,963
(7,640)
6,887
(3,158)
3,182
(1,619)
27,469
(15,528)
17,985
(12,238)
3,423
(2,706)
2,209
(1,759)
3,638
(3,245)
1,699
(1,591)
0
0
0
(276)
59,156
(33,124)
41,038
(25,123)
Gross profit (loss)
% on net sales
9,252
52.2%
8,323
52.1%
3,729
54.1%
1,563
49.1%
11,941
43.5%
5,747
32.0%
717
20.9%
450
20.4%
393
10.8%
108
6.4%
0
n.a.
(276)
n.a.
26,032
44.0%
15,915
38.8%
Operating expenses and other income (expenses)
Operating income (loss)
(3,664)
5,588
(3,011)
5,312
(1,523)
2,206
(935)
628
(2,433)
9,508
(2,132)
3,615
(334)
383
(281)
169
(927)
(534)
(828)
(720)
(6,897)
(6,897)
(6,490)
(6,766)
(15,778)
10,254
(13,677)
2,238
% on net sales 31.5% 33.3% 32.0% 19.7% 34.6% 20.1% 11.2% 7.7% -14.7% -42.4% n.a. n.a. 17.3% 5.5%
Thousands of euro
SAES Industrial SAES High Vacuum SAES Medical Nitinol SAES Chemicals SAES Packaging Not Allocated TOTAL
1Q 2022 4Q 2021 1Q 2022 4Q 2021 1Q 2022 4Q 2021 1Q 2022 4Q 2021 1Q 2022 4Q 2021 1Q 2022 4Q 2021 1Q 2022 4Q 2021
Total net sales 17,739 15,894 6,887 6,901 27,469 23,978 3,423 4,376 3,638 1,909 0 0 59,156 53,058
Cost of sales
Gross profit (loss)
9,252 (8,487)
(8,296)
7,598
(3,158)
3,729
(3,386)
3,515
(15,528)
11,941
(13,237)
10,741
(2,706)
717
(3,244)
1,132
(3,245)
393
(1,602)
307
0
0
(3)
(3)
(33,124)
26,032
(29,768)
23,290
% on net sales
Operating expenses and other income (expenses)
52.2%
(3,664)
47.8%
(3,141)
54.1%
(1,523)
50.9%
(1,676)
43.5%
(2,433)
44.8%
(2,203)
20.9%
(334)
25.9%
(373)
10.8%
(927)
16.1%
(3,614)
n.a.
(6,897)
n.a.
(6,652)
44.0%
(15,778)
43.9%
(17,659)
SAES Group – Press Release
Operating expenses and other income (expenses)
Operating income (loss)
(3,664)
5,588
(3,011)
5,312
(1,523)
2,206
(935)
628
(2,433)
9,508
(2,132)
3,615
(334)
383
(281)
169
(927)
(534)
(828)
(720)
(6,897)
(6,897)
(6,490)
(6,766)
(15,778)
10,254
(13,677)
2,238
% on net sales 31.5% 33.3% 32.0% 19.7% 34.6% 20.1% 11.2% 7.7% -14.7% -42.4% n.a. n.a. 17.3% 5.5%
Thousands of euro SAES Industrial SAES High Vacuum SAES Medical Nitinol SAES Chemicals SAES Packaging Not Allocated TOTAL
Total net sales 1Q 2022
17,739
4Q 2021
15,894
1Q 2022
6,887
4Q 2021
6,901
1Q 2022
27,469
4Q 2021
23,978
1Q 2022
3,423
4Q 2021
4,376
1Q 2022
3,638
4Q 2021
1,909
1Q 2022
0
4Q 2021
0
1Q 2022
59,156
4Q 2021
53,058
Cost of sales (8,487)
(8,296)
(3,158) (3,386) (15,528) (13,237) (2,706) (3,244) (3,245) (1,602) 0 (3) (33,124) (29,768)
Gross profit (loss)
% on net sales
9,252
52.2%
7,598
47.8%
3,729
54.1%
3,515
50.9%
11,941
43.5%
10,741
44.8%
717
20.9%
1,132
25.9%
393
10.8%
307
16.1%
0
n.a.
(3)
n.a.
26,032
44.0%
23,290
43.9%
Operating expenses and other income (expenses) (3,664) (3,141) (1,523) (1,676) (2,433) (2,203) (334) (373) (927) (3,614) (6,897) (6,652) (15,778) (17,659)
Operating income (loss)
% on net sales
5,588
31.5%
4,457
28.0%
2,206
32.0%
1,839
26.6%
9,508
34.6%
8,538
35.6%
383
11.2%
759
17.3%
(534)
-14.7%
(3,307)
-173.2%
(6,897)
n.a.
(6,655)
n.a.
10,254
17.3%
5,631
10.6%
Consolidated EBITDA5 was equal to €13.7 million (23.1% of revenues), increased if compared to both the first
quarter of 2021 (€5 million or 12.2% of revenues) and to the fourth quarter of 20216 (€10.4 million or 19.6%)
and reflected the operating income trend in all the Divisions.
Please note that, compared to the first quarter of 2021, the acquisition of Strumenti Scientifici Cinel S.r.l.
contributed to the increase in EBITDA for €0.3 million, while the exchange rate effect was positive and equal
to €1.1 million.
Thousands of euro
1Q 2022 1Q 2021 4Q 2021
Operating income (loss) 10,254 2,238 5,631
Depreciation & amortization (3,182) (2,763) (3,210)
Write-down of assets (219) (7) (1,500)
Bad debt provision (Accrual)/Release (28) 1 (54)
quarter of 2021 (€5 million or 12.2% of revenues) and to the fourth quarter of 20216
Please note that, compared to the first quarter of 2021, the acquisition of Strumenti Scientifici Cinel S.r.l.
contributed to the increase in EBITDA for €0.3 million, while the exchange rate effect was positive and equal
Thousands of euro
Operating income (loss) 1Q 2022
10,254
1Q 2021 2,238 4Q 2021 5,631
Depreciation & amortization (3,182) (2,763) (3,210)
Write-down of assets (219) (7) (1,500)
Bad debt provision (Accrual)/Release EBITDA (28)
13,683
1
5,007
(54)
10,395

Consolidated net income was equal to €1.9 million in the first quarter of 2022 (compared to €1.4 million in the corresponding quarter of 2021 and to €2.6 million in the fourth quarter of 2021) as it was heavily penalized by the negative performance of the securities portfolio (-€5.5 million) following the Ukraine-Russia crisis.

The consolidated net financial position was positive and equal to €71 million as at March 31, 2022 and compares with a positive net financial position equal to €74.8 million as at December 31, 2021. The decrease, despite a good result from operating activities (+€3.9 million) albeit penalized by the increase in the net working capital, was exclusively due to the decrease in the fair value of the securities in the portfolio following the Ukraine-Russia conflict (the performance of the securities was equal to -€5.5 million in the current quarter). Finally, please note a capex equal to -€2.4 million.

For further details, please refer to the following sections of this press release.

5 EBITDA is not deemed as an accounting measure under International Financial Reporting Standards (IFRSs); however, we believe that EBITDA is an important parameter for measuring the Group's performance and therefore it is presented as an alternative indicator. Since its calculation is not regulated by applicable accounting standards, the method applied by the Group may not be homogeneous with the ones adopted by other Groups. EBITDA is calculated as "Earnings before interests, taxes, depreciation and amortization".

6 Please note that the EBITDA in the fourth quarter of 2021 was penalized by the cancellation of the advance due to the not finalized potential acquisition in the packaging business (€1.1 million).

Significant events occurred in the first quarter of 2022

On January 24, 2022, the Italian Branch of Memry Corporation, based in Lainate, was established by notarial deed no. 996/671; this branch, together with the already operational German Branch, enables Memry Corporation's commercial expansion in the European market, also with scouting functions, with the aim of a larger penetration of the Group in the healthcare sector.

On January 31, 2022, the EUREKA! - Technology Transfer Fund ended its fundraising activities with a total fundraising of €62,675,500. On February 16, 2022, following the sixth and final Closing, the Parent Company obtained a reimbursement referring to both the costs and the investments of the fund, amounting to €5 thousand and SAES shareholding in the fund was diluted from 4.81% to 4.79%.

On March 7, 2022 SAES Getters S.p.A. made a payment of €49 thousand, including the share of the management fees and other costs, as well as the portion of an investment made by the fund in the company NOVAC S.r.l.7

On February 15, 2022, the Board of Directors of SAES Getters S.p.A. proposed the inclusion of the newly acquired Strumenti Scientifici Cinel S.r.l. in the scope of the national tax consolidation together with the other Group companies that are already part of it. The respective Boards of Directors approved this inclusion at the beginning of March. Therefore, Strumenti Scientifici Cinel S.r.l. is part of the national tax consolidation with retroactive effect starting from January 1, 2022.

On February 28, 2022, SAES RIAL Vacuum S.r.l. fully repaid the interest-bearing loan granted by the shareholder SAES Getters S.p.A. (principal amount equal to €49 thousand). On the same date, the joint venture also repaid the loan granted by the other shareholder, Rodofil S.r.l. (principal amount equal to €51 thousand).

On March 1, 2022, SAES Nitinol S.r.l. waived a further share of interest accrued on loans granted to the joint venture Actuator Solutions GmbH, amounting to €0.3 million8 . This waiver will have no effect on the consolidated financial statements, as the financial receivable related to the interest-bearing loan (both principal and interest amounts) had already been fully written down as at December 31, 2021, as it was deemed unlikely to be recovered.

Please note that the SAES Group decided to donate an amount of €100 thousand to support Ukraine. In particular, €70 thousand were given to a local volunteer network connected with the Ukrainian Embassy in Italy, and the remainder will be assigned to an Italian refugees' support organization.

SAES Industrial Division

Consolidated revenues of the SAES Industrial Division amounted to €17.7 million in the first quarter of 2022, up by 11.1% compared to €16 million in the corresponding quarter of 2021. The currency trend recorded a positive exchange rate effect equal to +4.6%, net of which revenues organically increased by 6.5%.

The organic increase was mainly concentrated in the SMA Materials business (+17.9%, equal to €0.5 million), mainly driven by the luxury sector and to a lesser extent by the consumer electronics and automotive sectors. A double-digit organic growth was also registered by the Sintered Materials business (+25.4%, equal to €0.5 million), thanks to an increase in demand in both the heat sink segment and in the electron emitter one.

7 NOVAC S.r.l. is an innovative start-up company operating in the field of electrical energy storage and release systems, through the development of a new type of supercapacitors, able to provide high power and very short charging times.

8 In addition to the interest share, equal to €0.5 million, that SAES Nitinol S.r.l. had already waived in June 2021.

SAES Group – Press Release
The Getters & Dispensers business was substantially stable: the increase in sales in the medical
diagnostics and electronic devices markets was offset by a slight decrease in the other businesses.
The table below shows the revenues in the first quarter of 2022 related to the different business
segments, with evidence of the exchange rate effect and of the organic change compared to the
corresponding period of 2021.
Thousands of euro (except %)
Total Organic Exchange rate
Business 1Q 2022 1Q 2021 difference
(%)
change
(%)
effect
(%)
Getters & Dispensers 11,738 11,217 4.6% 0.3% 4.3%
Sintered Materials
SMA Materials
2,560
3,441
1,900
2,846
34.7%
20.9%
25.4%
17.9%
9.3%
3.0%

Gross profit of the Industrial Division was equal to €9.3 million in the first quarter of 2022, showing a double-digit increase (+11.2%) compared to €8.3 million in the corresponding period of 2021 thanks to higher sales, against a perfectly aligned gross margin (52.2% in the first quarter of 2022 compared to 52.1% in the corresponding period of 2021).

Operating income of the Industrial Division was equal to €5.6 million, up by 5.2% compared to €5.3 million in the first quarter of 2021 thanks to higher sales, although selling expenses increased in absolute terms but were essentially unchanged as a percentage of revenues. The operating margin decreased from 33.3% to 31.5%.

SAES High Vacuum Division

Consolidated revenues of the SAES High Vacuum Division were equal to €6.9 million in the first quarter of 2022, more than doubled compared to €3.2 million in the corresponding quarter of 2021. The currency trend recorded a positive exchange rate effect equal to +4%, while organic growth was equal to 63.7% (€2 million in absolute terms). Please note the change in the scope of consolidation following the acquisition of Strumenti Scientifici Cinel S.r.l. in July 2021 that led to a further increase in revenues of €1.5 million (+48.7%). Business 1Q 2022 1Q 2021 SAES High Vacuum 6,887 3,182 116.4% 63.7% 4.0% 48.7%

The excellent result was due to higher sales of NEG vacuum pumps in all segments (particle accelerators, research institutes and industry), to which were added the revenues for the supply of vacuum systems to the RFX Consortium in Padua, active in experimental nuclear fusion.

The table below shows the revenues in the first quarter of 2022, with evidence of the exchange rate effect, the change in the scope of consolidation and the organic change compared to the corresponding period of 2021.

Total
difference
(%)
Organic
change
(%)
Exchange rate
effect
(%)
Perimeter
variation (%)
High Vacuum Solutions 6,887 3,182 116.4% 63.7% 4.0% 48.7%

Thousands of euro (except %)

Gross profit of the High Vacuum Division was equal to €3.7 million in the first quarter of 2022, more than doubled compared to €1.6 million in the first quarter of 2021, favored by higher sales, a different product mix and by the resulting economies of scale. Gross margin increased from 49.1% to 54.1%, despite the dilutive effect of the consolidation of Strumenti Scientifici Cinel S.r.l., that closed the first quarter of 2022 with a gross industrial margin slightly above 34%.

Operating income of the High Vacuum Division was equal to €2.2 million, more than tripled compared to €0.6 million in the first quarter of 2021, despite the slight increase in operating expenses, mainly attributable to the change in the scope of consolidation9 . The operating margin increased from 19.7% to 32%.

SAES Medical Nitinol Division

compared to €0.6 million in the first quarter of 2021, despite the slight increase in operating
expenses, mainly attributable to the change in the scope of consolidation9
increased from 19.7% to 32%.
. The operating margin
SAES Medical Nitinol Division
Consolidated revenues of the SAES Medical Nitinol Division were equal to €27.5 million in the first
quarter of 2022, up by 52.7% compared to €18 million in the corresponding period of 2021. The
exchange rate effect was positive and equal to +10.4%, net of which the organic increase was equal
to +42.3% (€7.6 million in absolute terms).
This increase was particularly significant, although it is necessary to consider that the first quarter of
2021 was still penalized by the pandemic and by the consequent postponement of elective surgeries.
The table below shows the revenues in the first quarter of 2022, with evidence of the exchange rate
effect and of the organic change compared to the corresponding period of 2021.
Thousands of euro (except %)
Business
1Q 2022 1Q 2021 Total
difference
Organic
change
Exchange rate
effect
Medical Nitinol 27,469 17,985 (%)
52.7%
(%)
42.3%
(%)
10.4%

Gross profit of the Medical Nitinol Division was equal to €11.9 million in the first quarter of 2022, more than doubled when compared to €5.7 million in the corresponding period of 2021, while gross margin increased from 32% to 43.5%: the excellent performance of the Division was related both to the increase in revenues and to the progressive improvement in the production yield of the new tube department.

Operating income of the Medical Nitinol Division was equal to €9.5 million (34.6% of revenues), almost tripled compared to €3.6 million (20.1% of revenues) in the first quarter of 2021: the increase in gross profit reflected on the operating income, only partially mitigated by higher operating expenses (slight increase in personnel expenses in the G&A department and exchange rate effect).

SAES Chemicals Division

Consolidated revenues of the SAES Chemicals Division were equal to €3.4 million in the first quarter of 2022, up by +55% compared to €2.2 million in the corresponding period of 2021. There was no exchange rate effect, being sales denominated exclusively in euro.

The very strong increase in sales of advanced materials for the consumer electronics segment was the result of the strong recovery in the final market's demand compared to the early months of 2021.

The table below shows the revenues in the first quarter of 2022, compared to the corresponding period of 2021.

9 Acquisition of Strumenti Scientifici Cinel S.r.l.

Thousands of euro (except %)
SAES Group – Press Release
Thousands of euro (except %)
Total Organic Exchange rate
Business 1Q 2022 1Q 2021 difference
(%)
change
(%)
effect
(%)
Chemicals 3,423 2,209 55.0% 55.0% 0.0%
SAES Chemicals 3,423 2,209 55.0% 55.0% 0.0%
Gross profit of the Chemicals Division was equal to €0.7 million in the first quarter of 2022, compared
to €0.4 million in the corresponding period of 2021, slightly up thanks to higher sales, with a gross
margin aligned in the two quarters (from 20.4% to 20.9%).

Operating income of the Chemicals Division was equal to €0.4 million (11.2% of revenues), compared to €0.2 million (7.7% of revenues) in the first quarter of 2021: the increase in operating income was in line with that of the gross profit and operating expenses were stable in absolute terms (€0.3 million in both periods).

SAES Packaging Division

Consolidated revenues of the SAES Packaging Division were equal to €3.6 million in the first quarter of 2022, more than doubled compared to €1.7 million in the first quarter of 2021. Sales were exclusively denominated in euro.

The excellent result was attributable to the strengthening of the growth already recorded at the end of 2021, following the strategic repositioning of SAES Coated Films S.p.A. from a coated films manufacturer into a packaging solution provider. In addition, please note that the market unavailability of some plastic raw materials favored a greater penetration of SAES products which are an alternative to them, generating an expansion of the traditional customer portfolio and allowing to introduce the innovative SAES barrier technology in the market with a greater contribution to sustainability. Business 1Q 2022 1Q 2021 SAES Packaging 3,638 1,699 114.1% 114.1% 0.0%

The table below shows the revenues in the first quarter of 2022 compared to the corresponding period in 2021.

Total
difference
(%)
Organic
change
(%)
Exchange rate
effect
(%)
Packaging Solutions 3,638 1,699 114.1% 114.1% 0.0%

Thousands of euro (except %)

Gross profit of the Packaging Division was equal to €0.4 million, more than tripled compared to €0.1 million in the first quarter of 2021, driven by increased revenues and by higher economies of scale (gross margin increased from 6.4% to 10.8%), despite the new lacquering line was not yet operating at full capacity.

The excellent industrial performance positively reflected at the operating level, with the operating loss decreasing from €-0.7 million in the first quarter of 2021 to €-0.5 million in the current period.

Not Allocated items

These include costs relating to basic research projects, aimed at diversifying into innovative businesses, as well as corporate costs (expenses that cannot be directly attributed or reasonably allocated to any business segment but refer to the Group as a whole).

The unallocated cost of goods sold, nil in 2022, was equal to -€0.3 million in the previous year and mainly referred to costs related to a project for the renovation and modernization of some production departments at the Lainate site, completed at the end of 2021.

Total unallocated operating costs amounted to -€6.8 million in the first quarter of 2022, compared to -€6.4 million in the corresponding period of 2021. The increase was mainly concentrated in R&D expenses (especially higher personnel and consultancy costs as well as costs for materials, aimed at the development of innovative and sustainable projects).

Finally, please note, under the item "other net income (expenses)" in the first quarter of 2022 the cost, equal to €70 thousand, for the donation to a local Ukrainian network connected with the Embassy in Italy.

Consolidated operating expenses were equal to €15.7 million (26.5% of revenues) in the first quarter of 2022, compared to €13.6 million (33.2% of revenues) in the corresponding period of the previous year. Net of the exchange rate effect (+€0.3 million), the increase in the first quarter of 2022 (equal to approximately €1.8 million) was concentrated in the selling expenses (higher personnel costs both for the increase in the workforce and for the change in the scope of consolidation related to the acquisition of Strumenti Scientifici Cinel S.r.l., as well as a slight increase in transport costs on sales) and in G&A expenses (also in this case, increase in the cost of personnel and expenses related to the aforementioned change in the scope of consolidation). R&D expenses slightly increased in absolute terms (personnel costs and consultancy costs, also related to the establishment of the new Design House department within the Parent Company, focused on the development of highly innovative and sustainable products and processes), but decreased as a percentage of revenues (from 6.9% to 5.4%).

***

The net balance of other net income (expenses) was substantially nil (negative for -€91 thousand) in the first quarter of 2022, compared to a still immaterial negative figure equal to -€57 thousand in the corresponding quarter of 2021. Please note that the amount recorded in the current quarter included the cost, equal to €70 thousand, for the donation to a local Ukrainian network connected with the Embassy in Italy.

The sum of the exchange rate differences recorded a slightly negative balance equal to -€152 thousand in the first quarter of 2022, compared with a negative figure of-€ 73 thousand in the corresponding quarter of the previous year (both mainly attributable to losses deriving from the fair value valuation of forward contracts entered to hedge dollar-based commercial transactions expected in the remainder of both years).

The net balance of financial income and expenses was negative and equal to -€5.8 million, almost entirely attributable to the decrease in the fair value of the securities portfolio following the crisis between Ukraine and Russia. Interest on both short-term and long-term loans amounted to -€0.1 million, showing a marked decrease compared to -€0.3 million in the first quarter of 2021, thanks to the early repayment by the Parent Company of almost all outstanding loans at the end of December 2021. In the first quarter of 2021 financial income and expenses were positive for +€0.3 million (mainly, net income on securities equal to +0.8 million, as well as the aforementioned interest equal to -€0.3 million).

The result deriving from the valuation with the equity method of the joint ventures was positive and equal to +€3 thousand in the first quarter of 2022, compared to a positive value of +€2 thousand as at March 31, 2021: in both years the result was fully attributable to the joint venture SAES RIAL Vacuum S.r.l.

Consolidated net income before taxes was positive and equal to +€4.3 million in the first quarter of 2022, almost doubled compared to +€2.5 million in the first quarter of 2021, despite the sharp reduction in the value of the securities portfolio due to conflict in Ukraine, thanks to the excellent performance of operating activities.

Income taxes amounted to €2.5 million in the first quarter of 2022, compared to €1.1 million in the first quarter of 2021, and mainly included the taxes of the US manufacturing companies. The increase in absolute terms was mainly attributable to the higher taxable income achieved by the latter, compared to the corresponding period of the previous year. 1Q 2022 1Q 2021 Net income (loss) per ordinary share 0.07861 0.03330 Net income (loss) per savings share 0.13855 0.13855

The Group's tax rate increased from 44.5% to 56.7%: the worsening was due to the fact that SAES Investments S.A. ended the quarter with a negative taxable income10, prudentially not valued as a deferred tax asset.

Consolidated net income was equal to +€1.9 million in the first quarter of 2022, increased when compared to +€1.4 million in the first quarter of the previous year.

In the first quarter of 2022 net income per ordinary share amounted to €0.07861 (compared to €0.03330 in the corresponding period of 2021) and net income per savings share amounted to €0.13855 (unchanged compared to the first quarter of 2021).

Euro

Net Financial Position

Consolidated net financial position as at March 31, 2022 was positive and equal to €71 million compared to a positive consolidated net financial position equal to €74.8 million as at December 31, 2021. The first quarter ended with a positive operating management of +€3.9 million, although penalized by the increase in net working capital (-€8.8 million). The latter was mainly due to higher trade receivables (a consequence of the higher sales in the Medical Nitinol and Packaging Divisions in the first quarter of 2022, compared to the last months of 2021) and to the increase in inventory (mainly in the Chemicals Division, in anticipation of higher sales expected in the coming months).

Investment activities absorbed cash for -€8 million (negative performance of the securities portfolio for - €5.5 million due to the financial crisis related to the Ukraine-Russia conflict and capex equal to -€2.4 million; finally, please note the payment of -€44 thousand to the venture capital fund EUREKA!).

The financial management was negative and equal to -€0.3 million (mainly interest on bank loans and leasing contracts).

On the other hand, the exchange rate effect was positive and equal to +€0.7 million, mainly related to the effect of the revaluation of both the dollar and the renminbi on the cash in these currencies compared to December 31, 2021.

10 Loss caused by the negative performance of the securities portfolio held by the company, subsequent to the crisis between Ukraine and Russia.

SAES Group – Press Release
December 31,
2021
9
29,509
29,518
1
94,655
9
0
94,665
(63,935)
(109)
0
(20)
(2,409)
(71,076) (66,473)
54,758 57,710
49
1,595 1,424
70,555 71,887
72,150 73,360
(52,182) (52,199)
(3,712) (4,070)
(55,894) (56,269)
16,256 17,091
71,014 74,801
March 31,
2022
9
35,569
35,578
0
90,256
0
0
90,256
(68,577)
(102)
(109)
(13)
(2,275)
0

Reclassifications on economic values relating to 2021

Starting from January 1, 2022, the Group is organized in the following technological competence areas (or "Divisions"):

  • SAES Industrial Division (that coincides with the previous Metallurgy Division, with the addition of all SAES products based on functionalized polymers that have a getter function - i.e. dispensable getters and dryers, barrier sealants with getter functions and fillers containing getter species - that move from the SAES Chemicals Division to the SAES Industrial Division for a rationalization based on their ultimate function, that is the selective absorption of gas in the packaging of devices. In fact, the getter function of these dispensable products, based on functionalized polymers, associate them to SAES more traditional getters, based on metal alloys);
  • SAES High Vacuum Division (unchanged and coinciding with the Vacuum Technology Division);
  • SAES Medical Nitinol Division (unchanged and previously named "Medical");
  • SAES Packaging Division (unchanged and previously named "Advanced Packaging");
  • SAES Chemicals Division, that includes both the "functional acoustic composites" business (functional composites for consumer electronics applications, already previously classified in this Division), and the "functional additives" business (new products currently being validated by prospects and based on the technological platforms of SAES functional materials).

Finally, please note that three main business lines have been identified within the SAES Industrial Division:

  • Getters & Dispensers (that, in addition to the aforementioned "organic electronics" business consisting of all products with a getter function reclassified by the Chemicals Division, bring together the businesses "security & defense", "electronic devices", "healthcare diagnostics", "lamps" and "thermal insulated devices");
  • Sintered Materials (unchanged, previously named "sintered components for electronic devices & lasers");
  • SMA Materials (unchanged, previously named "SMA industrial").
The economic figures relating to 2021 have been reclassified according to the new operating structure, to
allow a homogeneous comparison with 2022.
SAES Group – Press Release
(Thousands of euro)
Business 1Q 2021 Reclass. 1Q 2021
reclassified
4Q 2021 Reclass. 4Q 2021
reclassified
Security & Defense 4,290 0 4,290 4,121 0 4,121
Electronic Devices 3,421 0 3,421 3,575 0 3,575
Healthcare Diagnostics 1,219 0 1,219 1,461 0 1,461
Lamps 829 0 829 678 0 678
Thermal Insulated Devices 931 0 931 1,026 0 1,026
Organic Electronics 0 527 527 0 263 263
Getters & Dispensers 10,690 527 11,217 10,861 263 11,124
Sintered Materials 1,900 0 1,900 2,323 0 2,323
SMA Materials 2,846 0 2,846 2,447 0 2,447
SAES Industrial 15,436 527 15,963 15,631 263 15,894
High Vacuum Solutions
SAES High Vacuum
3,182
3,182
0
0
3,182
3,182
6,901
6,901
0
0
6,901
6,901
Medical Nitinol 17,985 0 17,985 23,978 0 23,978
SAES Medical Nitinol 17,985 0 17,985 23,978 0 23,978
Chemicals 2,736 (527) 2,209 4,639 (263) 4,376
SAES Chemicals 2,736 (527) 2,209 4,639 (263) 4,376
Packaging Solutions 1,699 0 1,699 1,909 0 1,909
SAES Packaging 1,699 0 1,699 1,909 0 1,909
Total Net Sales 41,038 0 41,038 53,058 0 53,058
Thousands of euro
SAES Industrial SAES High Vacuum SAES Medical Nitinol SAES Chemicals SAES Packaging Not Allocated TOTAL
10 2021 Reclass. 1O 2021
reclassified
10 2021 1Q 2021
reclassified
1O 2021 1O 2021
reclassified
10 2021 Reclass. 10 2021
reclassified
10 2021 1Q 2021
reclassified
10 2021 10 2021
reclassified
10 2021 Reclass. 1Q 2021
reclassified
Total net sales 15.436 527 15,963 3.182 3.182 17.985 17,985 2.736 (527) 2.209 1.699 1.699 41.038 41.038
Cost of sales 7.405 (235) (7,640) (1,619) (1.619) (12.238) (12.238) (1,994) 235 (1,759) (1.591) (1.591) (276) (276) (25, 123) (25, 123)
Gross profit (loss) 8.031 292 8.323 1.563 1.563 5.747 5.747 742 (292) 450 108 108 (276) (276) 15.915 15,915
% on net sales 52.0% 52.1% 49.1% 49.1% 32.0% 32.0% 27.1% 20.4% 6.4% 6.4% n.a. n.a. 38.8% 38.8%
Operating expenses and other income (2.807) (204) (3,011) (935) (935) (2, 132) (2, 132) (485) 204 (281) (828) (828) (6.490) (6.490) (13,677) (13, 677)
Operating income (loss) 5,224 5.312 628 628 3.615 3.615 257 (88) 169 (720) (720) (6,766) (6,766) 2,238 2,238
% on net sales 33.8% 33.3% 19.7% 19.7% 20.1% 20.1% 9.4% 7% $-42.4%$ $-42.4%$ n.a. n.a. 5.5% 5.5%

Since the mandate of Deloitte & Touche S.p.A. for the legal audit of the accounts for the financial years 2013- 2021 expired after the approval of the Financial Statements as at December 31, 2021, on April 21, 2022 the Ordinary Shareholders' Meeting approved the reasoned proposal of the Board of Statutory Auditors regarding the assignment of the legal audit of the accounts for the financial years 2022-2030 to KPMG S.p.A.

On April 22, 2022, on the occasion of the Earth Day, the B!POD project (www.bipod.it) developed by the Design House of SAES was launched, aimed at using the Group's innovative technologies to improve food preservation and combat waste, while reducing CO2 emissions. In particular, the first device of B!POD, called DRO!D, was presented to the public: a system of recyclable plastic containers which allows to preserve different types of food five times more than usual through vacuum techniques. The device is characterized by highly innovative design and colors and by the use of entirely green plastics and materials.

Please note that the performance of the Group's securities portfolio was negative and equal to approximately -1.80% during the month of April 2022.

Following the completion of the due diligence, the Board of Directors of SAES Getters S.p.A. resolved to proceed with the acquisition of the entire share capital of SAES RIAL Vacuum S.r.l., of which SAES already holds 49%.

SAES RIAL Vacuum S.r.l., established at the end of 2015 and jointly controlled by SAES Getters S.p.A. (49%) and Rodofil S.r.l. (51%) is specialized in the design and manufacturing of vacuum chambers for accelerators, synchrotrons and industrial applications. The acquisition follows that of Strumenti Scientific Cinel S.r.l. (July 2021) and aims at strengthening the Group's competitive position in the high vacuum sector, through an expansion and integration of the offer, which is entirely Italian and at the forefront on a global scale.

The consideration for the acquisition will be equal to around €5.25 million and the closing is expected in the next few weeks, because of the technical time required to formalize the operation. A first tranche of the consideration, equal to €4,750 thousand, will be paid by SAES at the closing; the remaining part, equal to €500 thousand, will be withheld as a guarantee and paid in three successive annual installments of the same amount (each worth €166.7 thousand) starting from the thirty-sixth month following the signing of the deed of sale (March 2, 2022).

SAES RIAL Vacuum S.r.l., currently consolidated by using the equity method, recorded net revenues equal to €7 million and a net income equal to €0.4 million in 2021(net revenues equal to €5.6 million and a net income equal to €0.6 million in 2020). As at March 31, 2022, its shareholders' equity was equal to €2 million, while the net financial position was negative for €0.7 million.

Business Outlook

We expect the current situation of the Group to continue in the coming months.

Please note that the Group's direct exposure in Russia, Ukraine and Belarus is negligible. In 2021 the revenues, concentrated only in Russia, were immaterial. Also the forecasts for 2022, prepared before the crisis, confirm the irrelevance of these markets. Moreover, the Group has no suppliers from these countries and in any case it has decided to cautiously suspend any commercial activity towards Russia.

The unpredictable dynamics of the geopolitical, military and economic developments of the crisis, combined with the complex interdependencies among the world's economies and supply chains, do not allow us to provide firm estimates of the crisis' impact. The expected results of the operating activities are influenced by the evolution of the global macroeconomic context and the consequent repercussions on the cost of raw materials and energy.

***

Please note that these figures are taken from the Additional periodic financial information as at March 31, 2022, not subject to audit. This document will be available to the public both on the Company's website (www.saesgetters.com/investor-relations/financial-reports) and on the centralized storage system () within today.

The Officer responsible for the preparation of corporate financial reports of SAES Getters S.p.A. certifies that, in accordance with the second subsection of article 154-bis, part IV, title III, second paragraph, section V-bis, of Legislative Decree February 24, 1998, no. 58, the financial information included in the present document corresponds to book of account and book-keeping entries.

***

The Officer responsible for the preparation of corporate financial reports Giulio Canale

***

SAES Group

A pioneer in the development of getter technology, the SAES® Group is the world leader in a variety of scientific and industrial applications where stringent vacuum conditions are required. In 80 years of activity, the Group's getter solutions have been supporting technological innovation in the information display and lamp industries, in sophisticated high vacuum systems and in vacuum thermal insulation, in technologies spanning from large vacuum power tubes to miniaturized silicon-based microelectronic and micromechanical devices (MEMS).

Starting in 2004, by leveraging the core competencies in special metallurgy and in the materials science, the SAES Group has expanded its business into the advanced material markets, in particular the market of shape memory alloys, a family of materials characterized by super elasticity and by the property of assuming predefined forms when subjected to heat treatment. These special alloys, which

today are mainly applied in the biomedical sector, are also perfectly suited to the realization of actuator devices for the industrial sector (domotics, white goods industry, consumer electronics, healthcare, automotive and luxury sector).

More recently, SAES has expanded its business by developing a technological platform that integrates getter materials in a polymeric matrix. These products, initially developed for OLED displays, are currently used in new application sectors, among which optoelectronics, photonics and the mobile sector. Among the new applications, the advanced packaging is a significantly strategic one, in which SAES is offering a range of new products for the food sustainable packaging and aims to compete with recyclable and compostable solutions.

A total production capacity distributed in eleven facilities, a worldwide-based sale & service network and over 1,100 employees the Group is able to combine multi-cultural skills and experience and to be a truly global enterprise.

SAES Group is headquartered in the Milan area (Italy).

SAES Getters S.p.A. is listed on the Italian Stock Exchange Market, Euronext STAR segment, since 1986.

More information on the SAES Group is available in the website www.saesgetters.com.

Contacts:

Emanuela Foglia Investor Relations Manager Tel. +39 02 93178 273 E-mail: [email protected]

Corporate Media Relations Close to Media Tel. +39 02 70006237 Nicola Guglielmi E-mail: [email protected] Fiorella Poppi E-mail: [email protected]

SAES Industrial Division
Getters & Dispensers advanced photonics markets) Traditional getters and dispensers, based on metal alloys, for several industrial
applications (electronic vacuum devices for application in the security & defense
sector, MEMS, X-ray tubes for diagnostic imaging systems, lighting and thermal
insulation products, etc.), as well as dispensable getters based on functionalized
polymers (OLED applications for the consumer electronics, optoelectronics and
Sintered Materials solid-state components and lasers Dispensable cathodes for electronic tubes and devices for thermal dissipation in
SMA Materials Shape memory alloys and super elastic materials and components for the industrial
sector (domotics, white goods industry, consumer electronics, non-implantable
medical business, automotive and luxury sector)
SAES High Vacuum Division
High Vacuum Solutions research and in particle accelerators Getter pumps for vacuum systems that find application in the industrial sector, in
SAES Medical Nitinol Division
Medical Nitinol Nitinol raw material and components for the biomedical sector
SAES Chemicals Division
Chemicals Functional acoustic composites for consumer electronics applications and new
functional materials being validated by prospects
SAES Packaging Division
Packaging Solutions Lacquers and advanced plastic films for the sustainable packaging sector
Consolidated Net Sales by Geographic Location of Customer
Thousands of euro
Geographic Area 1Q 2022 1Q 2021
Italy 1,771 1,211
European Countries 11,769 7,920
North America 34,185 23,198
Japan 1,857 1,936

Consolidated Net Sales by Geographic Location of Customer

Medical Nitinol Nitinol raw material and components for the biomedical sector
SAES Chemicals Division
Chemicals Functional acoustic composites for consumer electronics applications and new
functional materials being validated by prospects
SAES Packaging Division
Packaging Solutions Lacquers and advanced plastic films for the sustainable packaging sector
Consolidated Net Sales by Geographic Location of Customer
Thousands of euro
Italy 1,771 1,211
European Countries 11,769 7,920
North America 34,185 23,198
Japan 1,857 1,936
South Korea 687 501
China 6,168 4,795
Rest of Asia 1,390 1,064
Rest of the World 1,329 413
Total Net Sales 59,156 41,038

Consolidated statement of profit or loss

Thousands of euro

1Q 2022 1Q 2021
Total net sales 59,156 41,038
Cost of sales (33,124) (25,123)
Gross profit 26,032 15,915
R&D expenses (3,193) (2,828)
Selling expenses (3,813) (2,912)
G&A expenses (8,653) (7,881)
Write-down of trade receivables (28) 1
Total operating expenses (15,687) (13,620)
Other income (expenses), net (91) (57)
Operating income (loss) 10,254 2,238
Interest and other financial income, net (5,655) 491
Write-down of financial receivables and other financial assets (130) (168)
Income (loss) from equity method evalueted companies 3 2
Foreign exchange gains (losses), net (152) (73)
Income (loss) before taxes 4,320 2,490
Income taxes (2,451) (1,109)
Net income (loss) from continued operations 1,869 1,381
Income (loss) from discontinued operations 0 0
Net income (loss) before minority interest 1,869 1,381
Net income (loss) pertaining to minority interest 0 0
Net income (loss) pertaining to the Group 1,869 1,381

Consolidated statement of other comprehensive income

Thousands of euro

1Q 2022 1Q 2021
Net income (loss) for the period from continued operations 1,869 1,381
Exchange differences on translation of foreign operations 2,659 5,357
Exchange differences on equity method evaluated companies 0 0
Total exchange differences 2,659 5,357
Total components that will be reclassified to the profit (loss) in the future 2,659 5,357
Other comprehensive income (loss), net of taxes 2,659 5,357
Total comprehensive income (loss), net of taxes 4,528 6,738
attributable to:
- Equity holders of the Parent Company 4,528 6,738
- Minority interests 0 0

Consolidated Statement of Financial Position

SAES Group – Press Release
Consolidated Statement of Financial Position
Thousands of euro
March 31, December 31,
2022 2021
Property, plant and equipment, net 84,093 83,543
Intangible assets 59,622 58,951
Right of use 5,886 6,399
Securities 70,555 71,887
Other non current assets 15,340 14,840
Current assets 206,868 195,252
Total Assets 442,364 430,872
Shareholders' equity 258,327 253,799
Minority interest in consolidated 0 0
Total Shareholders' Equity 258,327 253,799
Non current liabilities 77,524 75,759
Current liabilities 106,513 101,314
Total Liabilities and Shareholders' Equity 442,364 430,872
Consolidated Cash Flows Statement
Thousands of euro

Consolidated Cash Flows Statement

March 31, December 31,
Property, plant and equipment, net 2022
84,093
2021
83,543
Intangible assets 59,622 58,951
Right of use 5,886 6,399
Securities 70,555 71,887
Other non current assets 15,340 14,840
Current assets 206,868 195,252
Shareholders' equity 258,327 253,799
Minority interest in consolidated 0 0
Non current liabilities 77,524 75,759
Current liabilities 106,513 101,314
Total Liabilities and Shareholders' Equity 442,364 430,872
Consolidated Cash Flows Statement
Thousands of euro
1Q 2022 1Q 2021
Net income (loss) from continued operations 1,869 1,381
Current income taxes 1,611 998
Change in deferred income taxes 840
111
Depreciation, amortization and write down of non current assets 3,401 2,770
Net loss (gain) on disposal of fixed assets 0
(1)
Interest and other financial (income) expenses, net 5,928 (325)
Other non-monetary costs (revenues) (211) (828)
13,438 4,106
Change in operating assets and liabilities (8,847) (5,458)
Payments of termination indemnities and similar obligations (71)
(66)
Financial income received, net of payment of interests (101) (8)
Taxes paid (545) (309)
Net cash provided by (used by) operating activities 3,874 (1,735)
Purchase of tangible and intangible assets, net of proceeds from sales (2,431) (3,095)
Purchase of securities, net of disinvestments (270) 213
Income from securities, net of management fees 474
626
Purchase of other investments (44)
(26)
Cash flows provided by (used by) investing activities (2,271) (2,282)
Proceeds from financial liabilities, net of repayments 4,275 1,448
Financial receivables repaid (granted) from related parties 49
0
Financial receivables repaid (granted) from third parties (148) 0
Interests receipts on financial receivables from related parties 1
1
Dividends payment 0
0
Interests and other expenses paid on loans
Repayment of financial liabilities for leased assets (interests included)
(148)
(649)
(365)
(627)
0
457
1,404
(2,156)
30,700
Cash and cash equivalents at the end of the period 34,997 28,544
Other financial liabilities/assets
Cash flows provided by (used by) financing activities
Effect of exchange rate differences
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the period
3,375
5,711
29,286
(5)
733

Actuator Solutions - SAES Group interest (50%)

SAES Group – Press Release
***
Actuator Solutions - SAES Group interest (50%)
Thousands of euro March 31, December 31,
Actuator Solutions GmbH 2022 2021
Statement of financial position 50% 50%
Non current assets 2,568 2,654
Current assets 1,062 1,127
Total Assets 3,630 3,781
Non current liabilities 4,000 4,025
Current liabilities 1,748 1,878
Total Liabilities 5,748 5,903
Capital Stock, Reserves and Retained Earnings (2,122) (2,711)
Net income (loss) for the period 4 589
Other comprehensive income (loss) for the period 0 0
Total Equity (2,118) (2,122)
Actuator Solutions GmbH 1Q 2022 1Q 2021
Statement of profit or loss 50% 50%
Total net sales 734 2,163
Cost of sales (537) (1,441)
Gross profit 197 722
Total operating expenses (321) (301)
Other income (expenses), net 0 5
Operating income (loss)
Interests and other financial income, net
(124)
126
426
(70)
Foreign exchange gains (losses), net 1 (5)
Income taxes 1 0
Net income (loss) 4 351
Exchange differences 0 0
Total comprehensive income (loss) for the period 4 351
SAES RIAL Vacuum S.r.l. - SAES Group interest (49%)
Thousands of euro
March 31, December 31,
SAES RIAL Vacuum S.r.l. 2022 2021
Statement of financial position 49% 49%
Non current assets 449 316
Current assets 1,651 1,693
Total Assets 2,100 2,009
Non current liabilities 232 178
896 862
Current liabilities
Total Liabilities 1,128 1,040
Capital Stock, Reserves and Retained Earnings 969
759

SAES RIAL Vacuum S.r.l. - SAES Group interest (49%)

Other income (expenses), net 0 5
Interests and other financial income, net 126 (70)
Foreign exchange gains (losses), net 1 (5)
Income taxes 1 0
Exchange differences 0 0
SAES RIAL Vacuum S.r.l. - SAES Group interest (49%)
Thousands of euro
SAES RIAL Vacuum S.r.l. March 31, December 31,
2022 2021
Non current assets 449 316
Current assets 1,651 1,693
Total Assets 2,100 2,009
Non current liabilities 232 178
Current liabilities 896 862
Total Liabilities 1,128 1,040
Capital Stock, Reserves and Retained Earnings 969
759
200
Net income (loss) for the period 3
Other comprehensive income (loss) for the period (*) 0
10
Total Equity 972 969
SAES Group – Press Release
SAES RIAL Vacuum S.r.l. 1Q 2022 1Q 2021
Statement of profit or loss 49% 49%
Total net sales 497 626
Cost of sales (448) (580)
Gross profit 49 46
Total operating expenses (56) (80)
Other income (expenses), net 16 38
Operating income (loss) 9 4
Interests and other financial income, net (3) (3)
Foreign exchange gains (losses), net (3) 1
Income taxes 0 0
Net income (loss) 3 2
Actuarial gain (loss) on defined benefit plans, net of 0 0
Totale comprehensive income (loss) for the period 3 2
Flexterra - SAES Group interest (46.84%)
Thousands of euro
Flexterra March 31, December 31,
2022 2021
Statement of financial position 46.84% 46.84%
Non current assets 5,363 5,425
Current assets 585 808
Total Assets 5,948 6,233
Non current liabilities 0 7

Flexterra - SAES Group interest (46.84%)

Cost of sales (448) (580)
Total operating expenses (56) (80)
Other income (expenses), net 16 38
Interests and other financial income, net (3) (3)
Foreign exchange gains (losses), net (3) 1
Income taxes 0 0
Actuarial gain (loss) on defined benefit plans, net of 0 0
Flexterra - SAES Group interest (46.84%)
Thousands of euro
March 31, December 31,
Flexterra 2022 2021
Statement of financial position 46.84% 46.84%
Non current assets 5,363 5,425
Current assets 585 808
Total Assets 5,948 6,233
Non current liabilities 0 7
Current liabilities 2,499 2,476
Total Liabilities 2,499 2,483
Capital Stock, Reserves and Retained Earnings 3,577 5,154
Reserve for stock options plan 173 173
Net income (loss) for the period (447) (1,917)
Other comprehensive income (loss) for the period (*) 146 340
Total Equity 3,449 3,750
(*) Currency translation differences arising from the conversion in euro of the financial statements of Flexterra, Inc.
and of Flexterra Taiwan Co., Ltd.
Flexterra 1Q 2022 1Q 2021
Statement of profit or loss 46.84% 46.73%
Total net sales 0 0
Cost of sales 0 0
Gross profit 0 0
Total operating expenses (324) (479)
Other income (expenses), net 0 2
Operating income (loss) (324) (477)
Interests and other financial income, net (43) (26)
0 7
2,499 2,476
3,577 5,154
173 173
(447) (1,917)
(*) Currency translation differences arising from the conversion in euro of the financial statements of Flexterra, Inc.
and of Flexterra Taiwan Co., Ltd.
0 0
0 0
0 0
(324) (479)
0 2
(324) (477)
(43) (26)
(84) (30)
5
4
(447)
(528)
146 260

Talk to a Data Expert

Have a question? We'll get back to you promptly.